Close

LANXESS: Matthias L. Wolfgruber voted in as new Chairman of the Supervisory Board

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Dr. Matthias L. Wolfgruber (64) is the new Chairman of the Supervisory Board of LANXESS AG.

At its constituent meeting, the Supervisory Board of the specialty chemicals company elected the doctor of chemistry and former CEO of Altana AG as the successor to Dr. Rolf Stomberg (78), who resigned from his office after the end of today’s Annual Stockholders’ Meeting. Wolfgruber has been a member of the Supervisory Body as a stockholder representative since 2015.

“LANXESS has undergone extensive change in recent years, and is on a stable course for growth. We aim to bring the full potential of this Group to fruition in the years ahead. In my new role, I am looking forward to continuing down our chosen path and breaking new ground in conjunction with the Board of Management and all employees,” said Wolfgruber.

On his re-election to the Supervisory Board in 2015, Stomberg had announced that he would not be serving his full term of office. However, he will maintain links with the company: At its meeting today, the newly formed Supervisory Board appointed him as its Honorary Chairman. “Rolf Stomberg helped to write LANXESS’s story chapter by chapter, and it bears his own inimitable signature. We would like to thank Dr. Stomberg for his outstanding service to the company by making him Honorary Chairman of the Supervisory Board,” added Wolfgruber.

Pamela Knapp (60) has joined the LANXESS Supervisory Board as a new member. She was elected by the stockholders at the Annual Stockholders’ Meeting held today (May 15, 2018). The economics graduate was previously CFO at the listed market-research company GFK SE in Nuremberg, Germany. Prior to that, she held various managerial roles at the Siemens Group.

LANXESS is a leading specialty chemicals company with sales of EUR 9.7 billion in 2017 and about 19,200 employees in 25 countries. The company is currently represented at 74 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back